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Objectives 
Review diagnosis and 
management of  
• Graves 
• Hot nodules 
• Toxic nodular goiter 
• Thyroid storm 
• 24 y.o. with weight loss, 
proptosis, palpitations, heat 
intolerance and amenorrhea 
• 80 y.o. with fatigue and thyroid 
nodule 
• 65 y.o. with longstanding goiter 
and dysphagia 
• 40 y.o. with neck and ear pain 
and heat intolerance 
 
Hyperthyroidism 
Thyrotoxicosis  
• Weight loss, tremor, fatigue, 
amenorrhea, palpitations, heat 
intolerance, hyperdefecation 
• Apathetic thyrotoxicosis  
in elderly 
• FT4 levels do not always  
correlate with symptoms 


         FT4      TSH 
 
Graves    ↑   ↓  
Hot nodule   ↑  ↓  
Thyroiditis   ↑  ↓  
Toxic goiter   ↑  ↓ 
 
A thyroid scan and/or iodine uptake  
can help determine etiology 
DDx Hyperthyroidism 
Graves Disease  
   Diffuse 
increased 
uptake of 
radioactive 
iodine or 
technetium 
Toxic Nodular Gland 
Multiple nodules 
Enlarged gland 
Heterogeneous 
uptake with hot 
and cold nodules 
•Rarely malignant 
•Many are euthyroid 
•Remainder of gland 
suppressed 
Hyperfunctioning (Hot) Nodule 
Subacute Thyroiditis 
             Graves             Thyroiditis 
 
              TSIG                                      inflammation 
                  ↓                                                   ↓  
        thyroid  hormone         release of thyroid  
            synthesis                                      hormone 
                  ↓                                                   ↓  
           ↑ T4   ↑ T3                                  ↑ T4   ↑ T3 
                  ↓                                                   ↓   
        suppressed TSH                           suppressed TSH  
                                                                       ↓  
                                              ↓ thyroid hormone synthesis  
Graves Disease  
• Autoimmune 
• Thyroid stimulating antibodies bind 
to TSH receptors 
• Diffuse smooth thyroid enlargement 
• Orbitopathy in 5-10% 
• ↑ RAI uptake 
• ↑ free T4, ↓ TSH 
Graves Ophthalmopathy 
• Diplopia 
• Proptosis 
• Exophthalmos 
• Periorbital swelling 
• Bilateral or unilateral 
• Pulse 120, DTRs 
4+, diffuse tremor, 
anxious. 
• Palpitations 
• Heat intolerance 
• Hyperdefecation 
 
Graves  
• Work-up 
- FT4, TSH 
- Thyroid stimulating  
   immunoglobulin (TSIG) 
- TSH receptor antibodies 
- don’t routinely need T3 
• Treatment 
- methimazole 
- propylthiouracil 
- radioactive iodine 
- surgery 
Radioactive Iodine  
• Gland destruction 
• TSH receptor antibodies persist 
after treatment 
• Avoid RAI in patient with severe 
Graves ophthalmopathy 
• Single dose effective in 90% 
• Most become hypothyroid after  
2-3 months, time course variable 
 
 
Methimazole  
• Decreases thyroid stimulating 
immunoglobulin levels and 
blocks T4 synthesis 
• 30–40% have spontaneous 
remission after 1 year of 
therapy 
• Agranulocytosis – rare  
• Cholestatic hepatitis – rare  
 
Propylthiouracil 
(PTU) 
• Decreases conversion of 
T4 to T3 
• TID dosing 
• Use in 1st trimester of 
pregnancy 
 
 
• Recurrence is possible 
• Potential hypocalcemia and  
recurrent laryngeal nerve 
damage 
• Use for nodules or  
extremely large glands 
Surgery 
A 24 yo with Graves disease was treated with RAI 
9 months ago. Her free T4 was 3.1 (↑) at 
diagnosis.  Palpitations and heat intolerance are 
gone, her periods are regular, and her weight has 
normalized. 
 
FT4 1.4 (nl) 
TSH 0.05 (↓) 
 
Which of the following should you recommend? 
 
A. Start methimazole 
B. Another dose of RAI 
C. Measure T3 
D. No intervention 
 
• In Graves TSH may remain 
suppressed for months after 
treatment 
• Don’t make post-treatment 
decisions on TSH alone 
A 50 yo has a 1-month history of tremor, 
palpitations, and heat intolerance. His pulse is 
100, the thyroid is smooth and tender, and he 
has no proptosis.  
 
FT4 2.1 (↑)  
TSH 0.01 (↓) 
 
What should you do next? 
 
A. Thyroid scan 
B. Check T3 
C. Ultrasound 
D. Repeat TFT’s in 6 weeks 
• Painful gland, ear pain 
• Elevated ESR 
• Mild hyperthyroidism 
• Hyperthyroid phase followed by 
transient hypothyroidism 
• Usually resolves without Rx 
• Occurs postpartum too 
Subacute or Painless 
Thyroiditis 
Subacute Thyroiditis 
A 25 yo nursing assistant has a 2 month 
history of palpitations.  She is trying to lose 
weight.  On exam her thyroid is not palpable 
and she has a fine tremor. 
 
FT4 2.1, TSH 0.01, thyroglobulin ↓ 
 
What is the most likely diagnosis? 
 
A. Graves 
B. Surreptitious use of T4 
C. Subacute thyroiditis 
D. Hot nodule 
   
A 75 y.o. has lost weight, has 
palpitations and has noted 
declining energy.  On exam 
his thyroid is smooth and not 
enlarged.   
His TSH is 0.01 (0.2-4.2).  
The FT4 is 1.2 (0.9-1.5). 
• Repeat levels in 6 weeks 
• Measure T3 
• Measure TPO antibodies 
• Measure reverse T3 
What is the next step? 
• Normal free T4 and suppressed 
TSH 
• Symptoms of hyperthyroidism 
• Measure total T3 to confirm 
diagnosis 
• Apathetic thyrotoxicosis 
especially in elderly 
T3 Toxicosis 
During an evaluation for fatigue 
and muscle weakness an 80 y.o. 
is found to have a 1.5 cm thyroid 
nodule.  Her exam is otherwise 
normal.  Her TSH is 0.09 (0.2-
4.2), the free T4 is 1.6 (0.9-1.5).   
 
What is the next step in 
evaluating the nodule? 
A. Ultrasound 
B. Thyroid scan 
C. Fine needle aspiration 
D. TPO antibodies 
What is the next step? 
Hyperfunctioning (Hot) Nodule 
• 5-10% of nodules 
•  Malignancy 
 uncommon 
•  FNA not required 
• When T4 is elevated 
- surgery or radioactive 
  iodine 
• A 65 y.o. with 
  lifelong goiter 
• FT4 1.3, T3 
  1.2, TSH <0.01 
• No dysphagia  
  or palpitations 
• How to treat? 
Multinodular Goiter 
• Effects of suppressive therapy 
are variable 
• Thyroid hormone is risky when 
TSH is low or suppressed 
• No need for FNA unless there 
is a dominant nodule 
• Surgery is good option in some 
 
• Suppressive therapy not 
  uniformly effective 
• Cancer risk is the same in 
  solitary nodules and multinodular 
  goiter 
• Hyper or hypothyroid 
• Dysphagia, hoarseness with 
  substernal extension 
• Nodule size and characteristics  
  determine whether FNA  
  is necessary 
 
Multinodular Goiter 
A 70 yo with steroid-dependent asthma is 
admitted with CHF, atrial fibrillation, fever, 
and confusion. She has an enlarged thyroid, 
and her FT4 is 7 (↑↑).  Her ventricular rate is 
120.  She has received an IV β-blocker and 
100 mg hydrocortisone in the ICU. 
 
What should be done next? 
 
A. Radioactive iodine 
B. Propylthiouracil  
C. Cold iodine 
D. Technetium scan 
E. TSH receptor antibodies  
   
• Exaggerated symptoms  
of hyperthyroidism 
• Surgery, infection, iodine load may 
precipitate 
• Block T4 synthesis with PTU, then 
block T4 release with 
nonradioactive iodine 
• High mortality 
• Glucocorticoids and PTU decrease  
T4 → T3 conversion 
Thyroid Storm 
22 y.o. in first 
trimester with weight 
loss, tremor and 
tachycardia.  The 
thyroid is enlarged, 
pulse 110. 
 
FT4 3.4 (0.9-1.5) and 
TSH 0.01 (0.2-4.2). 
• Control of thyroid hormone secretion 
important in reducing preterm delivery, 
preeclampsia and IUGR 
• Propylthiouracil (PTU) in 1st trimester 
then methimazole (MMI) 
• PTU and MMI cross the placenta 
equally 
• MMI associated with scalp defect, 
aplasia cutis and choanal atresia 
Treatment of Hyperthyroidism  
in Pregnancy 
• Keep FT4 at upper limit of normal 
and monitor monthly 
• High doses of PTU or MMI can 
lead to fetal goiter or 
hypothyroidism 
• May be able to stop antithyroid 
agent in later stages of pregnancy 
• Breastfeeding is ok with both PTU 
and MMI 
During Pregnancy 
On a wellness screen a 70 y.o. 
woman has a free T4 of 1.2 
(0.9-1.5) and TSH of <0.05 
(0.2-4.2).  She feels fine and 
her exam is normal.  Her 
thyroid is irregular and mildly 
enlarged.  Her family history is 
negative for thyroid disease. 
• Elderly 
• Acute illness 
• Hypopituitarism  
• After treatment for thyrotoxicosis 
• Early or developing 
hyperthyroidism 
• T3 toxicosis 
Causes of Low TSH 
TSH 
FT4 
 High Low Normal 
T3 RIA Hyperthyroidism 2° Hypothyroidism 
Normal High 
Subclinical 
Hyperthyroidism 
T3 toxicosis 
Evaluation of Low TSH 
• No symptoms  
• Normal FT4 
• Normal T3 
• ↓ TSH 
• Multinodular goiter 
• Autonomous nodule(s) 
 
 
 
Subclinical Hyperthyroidism 
• Exogenous or endogenous 
• Prevalence 1-12% 
• More common in females 
• TSH may normalize spontaneously 
   in 50% 
• Progression to overt hyperthyroidism 
  is uncommon 
 
 
Subclinical Hyperthyroidism 
Incidence of Atrial Fibrillation in Subclinical 
Hyperthyroidism 
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Risk of Fracture in Women with Low TSH 
 
Ann Intern Med 2001 
• No long term clinical trials have 
assessed whether therapy 
improves cardiovascular or bone 
health in subclinical 
hyperthyroidism.   
• Treat based on risk factors and 
degree of TSH suppression. 
 
     
• Low risk, asymptomatic 
  - monitor TFT’s every 6-12 months 
• High risk 
  - elderly, CV disease 
  - get DXA scan 
  - technetium scan 
 
Subclinical Hyperthyroidism 
Thyroid Foundation of Canada 
Questions? 
